10 research outputs found
Patient disposition.
<p>AE, adverse event; CPA, Child-Pugh A group; CPB, Child-Pugh B group.</p
ALF-5755 efficacy in HBV or AIH related severe acute hepatitis.
<p>ALF-5755 efficacy in HBV or AIH related severe acute hepatitis.</p
Median time for patients to reach a PR rate > = 50% in the HBV-HAI patients receiving ALF-5755 (full line) or placebo (dotted line).
<p>Analysis was performed on the ITT group (n = 22). Comparison by log-rank test was significant at the 0.03 level.</p
Values of PR slope from H0 to H72 according to the etiology of the acute liver failure.
<p>Values of PR slope from H0 to H72 according to the etiology of the acute liver failure.</p
Comparative efficacy between ALF-5755 and placebo on the PR slope from H0 to H72 and the survival without liver transplantation.
<p>Comparative efficacy between ALF-5755 and placebo on the PR slope from H0 to H72 and the survival without liver transplantation.</p